检索结果-南通市图书馆

A comprehensive review on metallic biomaterials for airway stenosis repair

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Materials Science & Technology 2023年第21期152卷 148-158页

作者： huafang li Wubin Wu Xiwei liu Cuie Wen School of Materials Science and Engineering University of Science and Technology BeijingBeijing 100083China Lepu Medical Technology Co. LtdBeijing 102200China School of Engineering RMIT UniversityMelbourneVIC 3001Australia

In recent years,the incidence of airway stenosis in respiratory diseases increases year by year.Among many treatment methods,tracheal stent implantation is a very effective way.Metallic stents have been the first choice for tracheal stent implantation due to their excellent mechanical properties,low rate of migration,and minimal effect on the ciliary movement of the trachea.In this paper,the research progress of metal tracheal stents is introduced in detail from three aspects of mechanical properties,degradation properties,and biocompatibility,including traditional inert metallic tracheal stents and new degradable metallic tracheal stents,and its future research and development are prospected:although the current research on biodegradable metal tracheal stents is still in its infancy,with only some studies of magnesium-based,iron-based,and zinc-based tracheal stents,they are considered as the best material for preparing future metal tracheal scaffolds considering their biodegradability and biocompatibility.

关键词： Tracheal stenosis Inert metallic tracheal stent Degradable metallic tracheal stent Biocompatibility Degradation properties

Fatigue and corrosion fatigue behaviors of biodegradable Zn-li and Zn-Cu-li under physiological conditions

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Materials Science & Technology 2022年第36期131卷 48-59页

作者： huafang li Yan Huang Xiaojing Ji Cuie Wen Lu-Ning Wang Beijing Advanced Innovation Center for Materials Genome Engineering School of Materials Science and EngineeringUniversity of Science and Technology BeijingBeijing 100083China State Key Laboratory for Advanced Metals and Materials University of Science and Technology BeijingBeijing 100083China School of Engineering RMIT UniversityMelbourneVictoria 3001Australia

Zinc(Zn)alloys are emerging as a new class of biodegradable metallic materials due to their good biocompatibility,suitable biodegradability,and nontoxicity.However,the dynamic loading in the human body,along with the corrosive physiological environment,brings great challenges to the application of biodegradable Zn alloys.At present,there are few reports on the fatigue and corrosion fatigue properties of Zn alloys in simulated body fluid(SBF).In the present work,extruded Zn-0.8li and Zn-2Cu-0.8li alloys were selected in order to systematically evaluate their fatigue and corrosion fatigue behaviors both in air at ambient temperature and in SBF at 37℃.Results revealed that the fatigue limits of the extruded Zn-0.8li and Zn-2Cu-0.8li alloys were about 135 and 180 MPa,respectively,in air at ambient temperature.However,the fatigue limits of the two alloys decreased to 65 and 80 MPa,respectively,in SBF at 37℃and showed a linear relationship between the corrosion fatigue life and the stress amplitude.The sources of fatigue cracks in air were internal microstructural defects or weak mechanical properties of the material,while the initiation of corrosion pits on the surface was the main reason for the source of the formation of fatigue cracks in SBF.The fracture mode of the extruded Zn-0.8li and Zn-2Cu-0.8li alloys was quasi-cleavage fracturing.Compared to static immersion testing,cyclic loading significantly increased the corrosion rates of the two experimental alloys in a corrosion fatigue environment.

关键词： Biodegradable metals Biomedical applications Corrosion fatigue behaviors Fatigue behaviors Zinc alloys

Progress of biodegradable metals

在线全文

学校读者我要写书评

暂无评论

Progress in Natural Science:Materials International 2014年第5期24卷 414-422页

作者： huafang li Yufeng Zheng ling Qin Department of Materials Science and Engineering College of Engineering Peking University Department of Orthopedics & Traumatology The Chinese University of Hong Kong

Biodegradable metals(BMs) are metals and alloys expected to corrode gradually in vivo, with an appropriate host response elicited by released corrosion products, then dissolve completely upon fulfilling the mission to assist with tissue healing with no implant residues. In the present review article, three classes of BMs have been systematically reviewed, including Mg-based, Fe-based and Zn-based BMs.Among the three BM systems, Mg-based BMs, which now have several systems reported the successful of clinical trial results, are considered the vanguards and main force. Fe-based BMs, with pure iron and Fe–Mn based alloys as the most promising, are still on the animal test stage. Zn-based BMs, supposed to have the degradation rate between the fast Mg-based BMs and the slow Fe-based BMs, are a rising star with only several reports and need much further research. The future research and development direction for the BMs are proposed, based on the clinical requirements on controllable degradation rate, prolonged mechanical stability and excellent biocompatibility, by optimization of alloy composition design, regulation on microstructure and mechanical properties, and following surface modification.

关键词： Biodegradable metals Magnesium Iron Zinc Biocompatibility

Efficacy of Huadananshen mistura on insomnia: a randomized, double-blind, placebo-controlled, and multi-center clinical trial

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Journal of Traditional Chinese Medicine 2013年第4期33卷 423-427页

作者： huafang li Xiaoli Yan Ting li Jian Xu Qiaochu Wang Yifeng Xu Department of Psychiatry Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine Department of Insomnia Shanghai Chinese Medicine Hospital

OBJECTIVE: To evaluate the effect of Huadananshen mistura in clinical treatment of Chinese patients with insomnia. METHODS: In this randomized, double-blind, placebo-controlled, multi-center study, 244 patients with insomnia were randomly assigned to a placebo group, a low-dose (10 mL/day), or a high-dose (20 mL/day) mistura group. Efficacy was assessed by using the sleep dysfunction rating scale (SDRS) and Clinical Global Impression-Improvement (CGI-I) scores. Safety and tolerability assessments included emergent adverse events, laboratory tests, and electrocardiograms. RESULTS: Total SDRS scores decreased in all three groups, and there were significant differences between the placebo group and the lowand high-dose mistura groups (P=0.000). CGI-I ratings in the lowand high-dose mistura groups were sig-nificantly better than that of the placebo group (P= 0.000). Incidences of rebound insomnia were similar in all three groups (placebo group: 6.94% , low-dose mistura group: 12.99% , and high-dose mistura group: 10.96% ; P=0.475). The efficacy of Huadananshen mistura in the lowor high-dose group was significantly better than that of the placebo group (P=0.000), but with no significant difference found between the lowand high-dose mistura groups (P=0.887). The rates of adverse events were similar in the three groups (placebo 2.44% , low-dose mistura 0%, and high-dose mistura 5%; P=0.088). CONCLUSION: Huadananshen mistura is an effective and generally well-tolerated hypnotic medicine for the treatment of Chinese patients with insomnia.

关键词：临床试验失眠症多中心随机疗效临床治疗高剂量实验室检查

Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia

在线全文

学校读者我要写书评

暂无评论

General Psychiatry 2019年第1期32卷 14-21页

作者： Jiajun Weng Yan Zhang huafang li Yifeng Shen Wenjuan Yu Drug Clinical Trial Institution Shanghai Mental Health CenterShanghaiChina Psychiatry Shanghai Mental Health CenterShanghaiChina

Background Extrapyramidal symptoms (EPS) are one of the most common and neglected side effects during the treatment of schizophrenia. The risk factors of EPS in Chinese patients with schizophrenia and its relationship with psychiatric symptoms and mood symptoms of schizophrenia remain unknown. Aims The main objective of this study is to explore the risk factors of EPS caused by antipsychotics and the relationship between EPS and psychotic symptoms and mood symptoms of schizophrenia. Method This study included 679 patients with schizophrenia who have met the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders- Fourth Edition. Patients were divided into the EPS group and the non-EPS group according to the scale rating criteria and whether the anticholinergics have been used. The differences between demographic data and characters of drug intake were compared between the two groups, and the risk factors of EPS were selected between those factors. Correlation analysis was performed on the severity of schizophrenia (Positive and Negative Symptoms Scale (PANSS), Calgary Depression Scale for Schizophrenia (CDSS) score) and EPS scale (Simpson-Angus Scale (SAS), Barnes Akathisia Rating Scale (BARS), Abnormal Involuntary Movement Scale (AIMS) score) in 679 patients. The differences between the PANSS subscale score and the CDSS score between the EPS grong and the non-EPS group were compared. Result Compared with the non-EPS group, the EPS group patients are older, and they have a longer duration since first prescribed antipsychotics. The EPS group patients have higher frequency of atypical antipsychotics polytherapy and typical and atypical antipsychotics polytherapy or combined treatments with mood stabilisers. Logistic regression analysis shows that antipsychotics with high D2 receptor antagonistic effect and illness duration are the risk factors of EPS. The SAS score was significantly correlated with PANSS negative score, PANSS general psychopathological score and PANSS total score. The BARS

关键词： Study risk factors extrapyramidal symptoms induced

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

General Psychiatry 2021年第1期34卷 37-43页

作者： Wenjuan Yu Jingjing Huang Sidi He Lei Zhang Yifeng Shen huafang li Psychiatry Shanghai Mental Health CenterShanghai Jiao Tong University School of MedicineShanghaiChina Shanghai Clinical Research Center for Mental Health ShanghaiChina Shanghai Key Laboratory of Psychotic Disorders ShanghaiChina

Background Atypical antipsychotics as first-line drugs have been used in patients with schizophrenia in China and abroad.However,its safety still needs to be evaluated in a large population,especially in Chinese patients.Objective The main objective of this study is to evaluate the safety and related factors of long-term atypical antipsychotic use in patients with schizophrenia in China.The secondary objective includes the long-term efficacy of atypical antipsychotics in these patients,as well as pharmacoeconomic evaluation,population pharmacokinetic studies and pharmacogenomics studies.Methods This study has an observational design.The atypical antipsychotics include quetiapine,olanzapine,risperidone,aripiprazole,ziprasidone,paliperidone,amisulpride,perospirone and clozapine.Visits occur at 0,4,8,13,26,52,78,104,130 and 156 weeks.The efficacy evaluations include symptoms,social function,recurrence rate and hospitalisation.The safety measures include physical examination,vital signs,abdominal circumference,laboratory tests(such as blood cell analysis,blood biochemical tests and serum prolactin/thyroxine levels),12-lead ECG,extrapyramidal syndrome assessment,sexual function evaluation,medication and other adverse events.The secondary measures include the Positive and Negative Syndrome Scale,Clinical Global Impression-Severity of Illness Scale,Calgary Depression Scale for Schizophrenia,Personal and Social Performance Scale,relapse rate,drug consolidation,medical-related expenses,income,drug plasma concentration and genetic information.Results This is a large sample,non-interventional and long-term prospective clinical study designed to truly reflect the specific details of clinical practice,fully respect patients’needs,and understand patients’treatment intentions and actual treatment details.Conclusions This research method details the aims,methods,study design,strengths and limitations of the study.

关键词： patients atypical treatment

An overview of graphene-based hydroxyapatite composites for orthopedic applications

在线全文

学校读者我要写书评

暂无评论

Bioactive Materials 2018年第1期3卷 1-18页

作者： Ming li Pan Xiong Feng Yan Sijie li Changhong Ren Zhichen Yin Ang li huafang li Xunming Ji Yufeng Zheng Yan Cheng China-America Institute of Neuroscience Xuanwu HospitalCapital Medical UniversityBeijing 100053China Academy for Advanced Interdisciplinary Studies Peking UniversityBeijing 100871China Beijing Key Laboratory of Hypoxia Conditioning Translational Medicine Xuanwu Hospital of Capital Medical UniversityBeijing 100053China Department of Neurosurgery Xuanwu HospitalCapital Medical UniversityBeijing 100053China Department of Biomedical Engineering Columbia UniversityNew YorkNY 10032USA Musculoskeletal Research Laboratory Department of Orthopaedics&TraumatologyThe Chinese University of Hong KongHong Kong Special Administrative Region

Hydroxyapatite(HA)is an attractive bioceramic for hard tissue repair and regeneration due to its physicochemical similarities to natural apatite.However,its low fracture toughness,poor tensile strength and weak wear resistance become major obstacles for potential clinical applications.One promising method to tackle with these problems is exploiting graphene and its derivatives(graphene oxide and reduced graphene oxide)as nanoscale reinforcement fillers to fabricate graphene-based hydroxyapatite composites in the form of powders,coatings and scaffolds.The last few years witnessed increasing numbers of studies on the preparation,mechanical and biological evaluations of these novel materials.Herein,various preparation techniques,mechanical behaviors and toughen mechanism,the in vitro/in vivo biocompatible analysis,antibacterial properties of the graphene-based HA composites are presented in this review.

关键词： Graphene Hydroxyapatite Composites Bone tissue Biomedical devices

Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

General Psychiatry 2020年第4期33卷 194-200页

作者： Sidi He Wen Juan Yu Xiaoliang Wang Lei Zhang Nan Zhao Guanjun li Yi Feng Shen huafang li Shanghai Mental Health Center Shanghai Jiao Tong University School of MedicineShanghaiChina Shanghai Pudong New Area Mental Health Center ShanghaiChina Clinical Research Center Shanghai Jiao Tong University School of MedicineShanghaiChina Shanghai Key Laboratory of Psychotic Disorders ShanghaiChina

Background Hyperprolactinemia is a common adverse reaction in patients with schizophrenia who take antipsychotic drugs;it often leads to treatment noncompliance in patients and has an adverse effect on their prognosis.Aims This study aimed to explore the risk factors of elevated prolactin(PRL)caused by risperidone(RIS)and olanzapine(OLZ)and the relationship between PRL and fasting plasma glucose and lipids.Methods Patients with schizophrenia were divided into two groups:264 patients who were taking RIS and 175 patients who were taking OLZ.These two groups were further divided according to serum PRL levels:an elevated PRL group(>30ng/mL)and a normal PRL group(PRL<30ng/mL).The demographics,medication dosage,fasting plasma glucose,total cholesterol and triglycerides were compared in the two groups.Logistic regression analysis was performed to explore the risk factors of elevated PRL levels.Results Compared with the OLZ group,the RIS group had a greater number of patients with elevated PRL(155/264 vs 58/175).Either the RIS or the OLZ group,the proportion of elevated PRL was greater in female patients(RIS:x^2=6.76,p=0.009;OLZ:x^2=12.98,p<0.001)and with higher doses of the related drugs(RIS:U=-3.73,p<0.001;OLZ:U=-2.31,p=0.021).In patients taking RIS,the elevated PRL subgroup took the drug for a longer period(U=-2.76,p=0.006)and had lower triglyceride levels(U=2.76,p=0.006).In patients taking OLZ,the elevated PRL subgroup had lower fasting plasma glucose levels(U=2.29,p=0.022).Logistic regression analysis showed that gender,dose and fasting glucose levels were significantly associated with elevated PRL levels(RIS:p=0.001,OLZ:p<0.001;RIS:p<0.001;OLZ:p=0.003;RIS:p=0.020,OLZ:p=0.001,respectively).Conclusion Compared with OLZ,RIS had a greater effect on PRL in patients with schizophrenia,and in patients with schizophrenia taking RIS or OLZ,gender and dose were significantly correlated with the PRL value.Moreover,the plasma glucose level of the group with elevated PRL was lower than that of the group with normal PRL.The resu

关键词： elevated drugs dosage

Correlation of hair risperidone concentration and serum level among patients with schizophrenia

在线全文

学校读者我要写书评

暂无评论

General Psychiatry 2019年第1期32卷 35-42页

作者： Xiujia Sun lihua Wang Fuzhong Yang Juanjuan Ren Ping Jiang Hongmei liu huafang li Chunbo li Chen Zhang Shanghai Key Laboratory of Psychotic Disorders Shanghai Mental Health CenterShanghai Jiaotong University School of MedicineShanghai200030China Shanghai Mental Health Center Shanghai Jiaotong University School of MedicineShanghai200030China

Background Risperidone (RSP) has a rapid onset in vivo, low dosage and high plasma protein binding rate, therefore therapeutic drug monitoring (TDM) is needed to ensure safety in clinical treatment. However, compared with blood, hair is non-invasive, safe, non-infectious and easy to transport and store. Aims This study aims to investigate the correlations among the drug concentrations of RSP in hair and serum, which provides an experimental basis to explore hair as a novel biomaterial to meet the needs of clinical detection. Methods 34 patients with schizophrenia treated with RSP for more than 3 months were enrolled in this study. About 1 cm section of hair near the scalp was taken from the subjects, pretreated and detected by liquid chromatography-mass spectrometry. A correlation analysis was conducted among the drug concentrations in hair, the serum concentrations and the daily dosage. The data were analysed usi叩 SPSS 20.0 software. Results There was significant correlation between the hair concentration of RSP (two-tailed test, r=0.440, p=0.009) with the serum concentration of RSP, and the hair concentration of 9-hydroxyrisperidone (9-HR) with the serum concentration of 9-HR had no significant correlation (two-tailed test, r=-0.217, p=0.217);the total concentration of the RSP and 9-HR had no significant correlation between hair and serum (r=0.227, p=0.196). The dosage had no statistically significant correlation with the concentration of RSP in hair (r=0.207, p=0.241), 9-HR in hair (r=-0.194, p=0.271) and the total concentration of RSP and 9-HR in hair (r=0.188, p=0.288). There was no statistical correlation between the dosage and the concentration of RSP in serum (r=-0.059, p=0.741), but significant correlation between the dosage and 9-HR in serum (r=0.581 p<0.001) was found, and the correlation between the dosage and the total concentration of the two drugs RSP and 9-HR in serum was also significant (r=0.437, p=0.01). Conclusion The correlation analysis showed that the concentration of RSP in hair was statis

关键词： Correlation of hair risperidone concentration serum level among patients schizophrenia